SMARCC2 and central nervous system cancer: SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2 (SMARCC2) negatively regulates Wnt/β-catenin signaling by controlling c-Myc expression, thereby reducing glioma cell invasion and migration.56